Advertisement

Vestibular Migraine

  • Amy SchettinoEmail author
  • Dhasakumar Navaratnam
Chapter

Abstract

Vestibular migraine is a clinical syndrome of the central nervous system that is characterized by episodic vestibular symptoms and a history of migraines. It affects approximately 1% of the population [1] and is one of the most common diagnoses in children presenting with vertigo [2].

Keywords

Vestibular migraine Migraine-associated vertigo Migrainous vertigo Episodic vertigo Vertigo Dizziness Headache International Headache Society 

References

  1. 1.
    Neuhauser HK, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67(6):1028–33.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Lee JD, Kim CH, Hong SM, Kim SH, Suh MW, Kim MB, et al. Prevalence of vestibular and balance disorders in children and adolescents according to age: a multi-center study. Int J Pediatr Otorhinolaryngol. 2017;94:36–9.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Huppert D, Brandt T. Descriptions of vestibular migraine and Meniere’s disease in Greek and Chinese antiquity. Cephalalgia. 2017;37(4):385–90.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Escat H. De la migraine otique. VII Congrés International d’Otologie Bordeaux: Gounouillhon. 1904;1176.Google Scholar
  5. 5.
    Liveing E. On megrim, sick-headache, and some allied disorders: a contribution to the pathology of nerve-storms. London: Churchill; 1873.Google Scholar
  6. 6.
    Boenheim F. Über familiäre Hemicrania vestibularis. Neurol Centralbl. 1917;36:226–9.Google Scholar
  7. 7.
    Slater R. Benign recurrent vertigo. J Neurol Neurosurg Psychiatry. 1979;42(4):363–7.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984;107(Pt 4):1123–42.CrossRefGoogle Scholar
  9. 9.
    Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246(10):883–92.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167–72.Google Scholar
  11. 11.
    Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436–41.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Vukovic V, Plavec D, Galinovic I, Lovrencic-Huzjan A, Budisic M, Demarin V. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache. 2007;47(10):1427–35.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Yollu U, Uluduz DU, Yilmaz M, Yener HM, Akil F, Kuzu B, et al. Vestibular migraine screening in a migraine-diagnosed patient population, and assessment of vestibulocochlear function. Clin Otolaryngol. 2017;42(2):225–33.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Batu ED, Anlar B, Topcu M, Turanli G, Aysun S. Vertigo in childhood: a retrospective series of 100 children. Eur J Paediatr Neurol. 2015;19(2):226–32.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Jahn K, Langhagen T, Heinen F. Vertigo and dizziness in children. Curr Opin Neurol. 2015;28(1):78–82.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Geser R, Straumann D. Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol. 2012;3:169.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Zamergrad MV, Parfenov VA, Yakhno NN, Melnikov OA, Antonenko LM, Nefedovskaya LV, et al. Common causes of vertigo and dizziness in different age groups of patients. Bionanoscience. 2017;7(2):259–62.CrossRefGoogle Scholar
  18. 18.
    Colombo B, Teggi R. Vestibular migraine: who is the patient? Neurol Sci. 2017;38:107–10.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Van Ombergen A, Van Rompaey V, Van de Heyning P, Wuyts F. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol. 2015;36(1):133–8.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Park JH, Viirre E. Vestibular migraine may be an important cause of dizziness/vertigo in perimenopausal period. Med Hypotheses. 2010;75(5):409–14.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Abu-Arafeh I, Russell G. Paroxysmal vertigo as a migraine equivalent in children: a population-based study. Cephalalgia. 1995;15(1):22–5; discussion 4.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope. 1998;108(1 Pt 2):1–28.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Zhang Y, Kong Q, Chen J, Li L, Wang D, Zhou J. International classification of headache disorders 3rd edition beta-based field testing of vestibular migraine in China: demographic, clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia. 2016;36(3):240–8.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Nakashima K, Yokoyama Y, Shimoyama R, Saito H, Kuno N, Sano K, et al. Prevalence of neurological disorders in a Japanese town. Neuroepidemiology. 1996;15(4):208–13.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Sloane PD. Dizziness in primary care. Results from the National Ambulatory Medical Care Survey. J Fam Pract. 1989;29(1):33–8.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Neuhauser HK, von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology. 2005;65(6):898–904.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Murdin L, Schilder AGM. Epidemiology of balance symptoms and disorders in the community: a systematic review. Otol Neurotol. 2015;36(3):387–92.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Kroenke K, Lucas CA, Rosenberg ML, Scherokman BJ. Psychiatric disorders and functional impairment in patients with persistent dizziness. J Gen Intern Med. 1993;8(10):530–5.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Aragones JM, Fortes-Rego J, Fuste J, Cardozo A. Migraine: an alternative in the diagnosis of unclassified vertigo. Headache. 1993;33(3):125–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Savundra PA, Carroll JD, Davies RA, Luxon LM. Migraine-associated vertigo. Cephalalgia. 1997;17(4):505–10; discussion 487.PubMedCrossRefGoogle Scholar
  32. 32.
    Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706–15.PubMedCrossRefGoogle Scholar
  33. 33.
    Eggers SDZ, Neff BA, Shepard NT, Staab JP. Comorbidities in vestibular migraine. J Vestib Res Equilib Orientat. 2014;24(5–6):387–95.Google Scholar
  34. 34.
    Muelleman T, Shew M, Subbarayan R, Shum A, Sykes K, Staecker H, et al. Epidemiology of dizzy patient population in a neurotology clinic and predictors of peripheral etiology. Otol Neurotol. 2017;38(6):870–5.CrossRefGoogle Scholar
  35. 35.
    Tungvachirakul V, Lisnichuk H, O’Leary SJ. Epidemiology of vestibular vertigo in a neuro-otology clinic population in Thailand. J Laryngol Otol. 2014;128(Suppl 2):S31–8.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Eggers SD, Staab JP, Neff BA, Goulson AM, Carlson ML, Shepard NT. Investigation of the coherence of definite and probable vestibular migraine as distinct clinical entities. Otol Neurotol. 2011;32(7):1144–51.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Gurkov R, Kantner C, Strupp M, Flatz W, Krause E, Ertl-Wagner B. Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol. 2014;271(10):2661–7.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Neff BA, Staab JP, Eggers SD, Carlson ML, Schmitt WR, Van Abel KM, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Meniere’s disease, vestibular migraine, and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–44.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Dieterich M, Staab JP. Functional dizziness: from phobic postural vertigo and chronic subjective dizziness to persistent postural-perceptual dizziness. Curr Opin Neurol. 2017;30(1):107–13.PubMedCrossRefGoogle Scholar
  40. 40.
    von Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(Pt 2):365–74.Google Scholar
  41. 41.
    Polensek SH, Tusa RJ. Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurootol. 2010;15(4):241–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Espinosa-Sanchez JM, Lopez-Escamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015;6:6.CrossRefGoogle Scholar
  43. 43.
    Goadsby P, Charbit A, Andreou A, Akerman S, Holland P. Neurobiology of migraine. Neuroscience. 2009;161(2):327–41.PubMedCrossRefGoogle Scholar
  44. 44.
    Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365–91.PubMedCrossRefGoogle Scholar
  45. 45.
    Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Koçak E, Sen ZD, et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 2013;339(6123):1092–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Baloh RW. Neurotology of migraine. Headache. 1997;37(10):615–21.CrossRefGoogle Scholar
  47. 47.
    Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA-study. Cephalalgia: an international journal of headache. 2010;30(2):129–136. https://doi.org/:10.1111/j.1468-2982.2009.01904.x.CrossRefGoogle Scholar
  48. 48.
    Guidetti D, Rota E, Morelli N, Immovilli P. Migraine and stroke: “vascular” comorbidity. Front Neurol. 2014;5:193.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Baloh RW, Jacobson K, Fife T. Familial vestibulopathy: a new dominantly inherited syndrome. Neurology. 1994;44(1):20–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Baloh RW, Foster CA, Yue Q, Nelson SF. Familial migraine with vertigo and essential tremor. Neurology. 1996;46(2):458–60.PubMedCrossRefGoogle Scholar
  51. 51.
    Oh AK, Lee H, Jen JC, Corona S, Jacobson KM, Baloh RW. Familial benign recurrent vertigo. Am J Med Genet. 2001;100(4):287–91.PubMedCrossRefGoogle Scholar
  52. 52.
    Lee H, Jen JC, Wang H, Chen Z, Mamsa H, Sabatti C, et al. A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet. 2006;15(2):251–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Jen JC, Wang H, Lee H, Sabatti C, Trent R, Hannigan I, et al. Suggestive linkage to chromosome 6q in families with bilateral vestibulopathy. Neurology. 2004;63(12):2376–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Lee H, Jen JC, Cha YH, Nelson SF, Baloh RW. Phenotypic and genetic analysis of a large family with migraine-associated vertigo. Headache. 2008;48(10):1460–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Bahmad F Jr, DePalma SR, Merchant SN, Bezerra RL, Oliveira CA, Seidman CE, et al. Locus for familial migrainous vertigo disease maps to chromosome 5q35. Ann Otol Rhinol Laryngol. 2009;118(9):670–6.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33(2):192–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Requena T, Espinosa-Sanchez JM, Lopez-Escamez JA. Genetics of dizziness: cerebellar and vestibular disorders. Curr Opin Neurol. 2014;27(1):98–104.PubMedCrossRefGoogle Scholar
  58. 58.
    Pietrobon D. Calcium channels and migraine. Biochim Biophys Acta Biomembr. 2013;1828(7):1655–65.CrossRefGoogle Scholar
  59. 59.
    Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366(9483):371–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87(3):543–52.CrossRefGoogle Scholar
  61. 61.
    Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, et al. Corrigendum: meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48(10):1296.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48(8):856–66.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Lopez C, Blanke O. The thalamocortical vestibular system in animals and humans. Brain Res Rev. 2011;67(1):119–46.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Russo A, Marcelli V, Esposito F, Corvino V, Marcuccio L, Giannone A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120–6.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Shin JH, Kim YK, Kim HJ, Kim JS. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58–67.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Baier B, Eulenburg PZ, Best C, Geber C, Müller-Forell W, Birklein F, et al. Posterior insular cortex–a site of vestibular–somatosensory interaction? Brain Behav. 2013;3(5):519–24.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Garcia-Larrea L. The posterior insular-opercular region and the search of a primary cortex for pain. Neurophysiol Clin. 2012;42(5):299–313.PubMedCrossRefGoogle Scholar
  68. 68.
    Zu Eulenburg P, Baumgärtner U, Treede R-D, Dieterich M. Interoceptive and multimodal functions of the operculo-insular cortex: tactile, nociceptive and vestibular representations. NeuroImage. 2013;83:75–86.PubMedCrossRefGoogle Scholar
  69. 69.
    Brandt T, Bartenstein P, Janek A, Dieterich M. Reciprocal inhibitory visual-vestibular interaction. Visual motion stimulation deactivates the parieto-insular vestibular cortex. Brain J Neurol. 1998;121(9):1749–58.CrossRefGoogle Scholar
  70. 70.
    Russo A, Marcuccio L, Conte F, Caiazzo G, Giordano A, Conforti R, et al. No evidence of microstructural changes in patients with vestibular migraine: a diffusion tensor tract based spatial statistic (TBSS) study. J Headache Pain. 2015;16:2.CrossRefGoogle Scholar
  71. 71.
    Obermann M, Wurthmann S, Steinberg BS, Theysohn N, Diener HC, Naegel S. Central vestibular system modulation in vestibular migraine. Cephalalgia. 2014;34(13):1053–61.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Messina R, Rocca MA, Colombo B, Teggi R, Falini A, Comi G, et al. Structural brain abnormalities in patients with vestibular migraine. J Neurol. 2017;264(2):295–303.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Moretti G, Manzoni GC, Caffarra P, Parma M. “Benign recurrent vertigo” and its connection with migraine. Headache. 1980;20(6):344–6.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Stolte B, Holle D, Naegel S, Diener HC, Obermann M. Vestibular migraine. Cephalalgia. 2015;35(3):262–70.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    von Brevern M, Lempert T. Vestibular migraine. Hand. 2016;137:301–16.Google Scholar
  76. 76.
    Kuritzky A, Ziegler DK, Hassanein R. Vertigo, motion sickness and migraine. Headache. 1981;21(5):227–31.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Cass SP, Furman JM, Ankerstjerne K, Balaban C, Yetiser S, Aydogan B. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997;106(3):182–9.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Waterston J. Chronic migrainous vertigo. J Clin Neurosci. 2004;11(4):384–8.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Radtke A, von Brevern M, Neuhauser H, Hottenrott T, Lempert T. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607–14.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32(6):300–4.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Headache Classification Subcommittee of the International Headache S. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160.Google Scholar
  82. 82.
    Behan PO, Carlin J. Benign recurrent vertigo. In: Advances in migraine research and therapy. New York: Raven; 1982. p. 49–55.Google Scholar
  83. 83.
    Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia. 2004;24(2):83–91.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Parker W. Migraine and the vestibular system in adults. Am J Otol. 1991;12(1):25–34.PubMedPubMedCentralGoogle Scholar
  85. 85.
    Olsson JE. Neurotologic findings in basilar migraine. Laryngoscope. 1991;101(1):1–41.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Best C, Eckhardt-Henn A, Tschan R, Dieterich M. Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year. J Neurol. 2009;256(1):58–65.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Best C, Tschan R, Eckhardt-Henn A, Dieterich M. Who is at risk for ongoing dizziness and psychological strain after a vestibular disorder? Neuroscience. 2009;164(4):1579–87.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Staab JP. Behavioural neuro-otology. In: Oxford textbook of vertigo and imbalance. Oxford: Oxford University Press; 2013. p. 333.CrossRefGoogle Scholar
  89. 89.
    Kroenke K, Lucas CA, Rosenberg ML, Scherokman B, Herbers JE Jr, Wehrle PA, et al. Causes of persistent dizziness. A prospective study of 100 patients in ambulatory care. Ann Intern Med. 1992;117(11):898–904.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Post RE, Dickerson LM. Dizziness: a diagnostic approach. Am Fam Physician. 2010;82(4):361–8, 9.Google Scholar
  91. 91.
    Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55(1):21–34.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66(7):848–60.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Harris JP, Alexander TH. Current-day prevalence of Meniere’s syndrome. Audiol Neurootol. 2010;15(5):318–22.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007;78(7):710–5.CrossRefGoogle Scholar
  96. 96.
    Gannon RP, Willson GN, Roberts ME, Pearse HJ. Auditory and vestibular damage in head injuries at work. Arch Otolaryngol. 1978;104(7):404–8.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Kolev OI, Sergeeva M. Vestibular disorders following different types of head and neck trauma. Funct Neurol. 2016;31(2):75–80.PubMedPubMedCentralGoogle Scholar
  98. 98.
    Lucas S. Posttraumatic headache: clinical characterization and management. Curr Pain Headache Rep. 2015;19(10):48.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Lucas S. Characterization and management of headache after mild traumatic brain injury. In: Kobeissy FH, editor. Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects. Frontiers in neuroengineering. Boca Raton: CRC Press; 2015.CrossRefGoogle Scholar
  100. 100.
    Kim SK, Lee KJ, Hahm JR, Lee SM, Jung TS, Jung JH, et al. Clinical significance of the presence of autonomic and vestibular dysfunction in diabetic patients with peripheral neuropathy. Diabetes Metab J. 2012;36(1):64–9.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Alpini D, Caputo D, Pugnetti L, Giuliano DA, Cesarani A. Vertigo and multiple sclerosis: aspects of differential diagnosis. Neurol Sci. 2001;22(Suppl 2):S84–7.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Strupp M, Brandt T. Vestibular neuritis. Semin Neurol. 2009;29(5):509–19.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504–10.PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Foley RW, Shirazi S, Maweni RM, Walsh K, McConn Walsh R, Javadpour M, et al. Signs and symptoms of acoustic neuroma at initial presentation: an exploratory analysis. Cureus. 2017;9(11):e1846.PubMedPubMedCentralGoogle Scholar
  105. 105.
    Tarnutzer AA, Lee SH, Robinson KA, Kaplan PW, Newman-Toker DE. Clinical and electrographic findings in epileptic vertigo and dizziness: a systematic review. Neurology. 2015;84(15):1595–604.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Maldonado FM, Birdi JS, Irving GJ, Murdin L, Kivekäs I, Strupp M. Pharmacological agents for the prevention of vestibular migraine. Cochrane Database Syst Rev [Internet]. 2015;(6). Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010600.pub2/abstract, http://onlinelibrary.wiley.com/store/10.1002/14651858.CD010600.pub2/asset/CD010600.pdf?v=1&t=j8umolu7&s=1d8aa1ff72cb0e4cb10902e7c6727f8850d99717.
  107. 107.
    Neuhauser H, Lempert T. Vestibular migraine. Neurol Clin. 2009;27(2):379–91.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol. 2002;23(3):364–71.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Mikulec AA, Faraji F, Kinsella LJ. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology. Am J Otolaryngol. 2012;33(1):121–7.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Whitney SL, Wrisley DM, Brown KE, Furman JM. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope. 2000;110(9):1528–34.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Wrisley DM, Whitney SL, Furman JM. Vestibular rehabilitation outcomes in patients with a history of migraine. Otol Neurotol. 2002;23(4):483–7.PubMedCrossRefPubMedCentralGoogle Scholar
  112. 112.
    Vitkovic J, Winoto A, Rance G, Dowell R, Paine M. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–48.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Whitney SL, Sparto PJ. Principles of vestibular physical therapy rehabilitation. NeuroRehabilitation. 2011;29(2):157–66.PubMedPubMedCentralGoogle Scholar
  114. 114.
    Staab JP. Chronic dizziness: the interface between psychiatry and neuro-otology. Curr Opin Neurol. 2006;19(1):41–8.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60(5):882–3.PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18(3):350–4.PubMedPubMedCentralGoogle Scholar
  117. 117.
    Cassano D, Pizza V, Busillo V. Almotriptan in the acute treatment of Vestibular migraine: a retrospective study. J Headache Pain. 2015;16:2.CrossRefGoogle Scholar
  118. 118.
    Prakash S, Chavda BV, Mandalia H, Dhawan R, Padmanabhan D. Headaches related to triptans therapy in patients of migrainous vertigo. J Headache Pain. 2008;9(3):185–8.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Marcus DA, Furman JM. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. Med Sci Monit. 2006;12(1):PI1–7.PubMedPubMedCentralGoogle Scholar
  120. 120.
    Prakash S, Shah ND. Migrainous vertigo responsive to intravenous methylprednisolone: case reports. Headache. 2009;49(8):1235–9.PubMedCrossRefPubMedCentralGoogle Scholar
  121. 121.
    Strupp M, Dieterich M, Brandt T. The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int. 2013;110(29–30):505–15; quiz 15–6.Google Scholar
  122. 122.
    Seemungal B, Kaski D, Lopez-Escamez JA. Early diagnosis and management of acute vertigo from vestibular migraine and Meniere’s disease. Neurol Clin. 2015;33(3):619–28, ix.PubMedCrossRefPubMedCentralGoogle Scholar
  123. 123.
    Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A, et al. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One. 2015;10(7):e0130733.PubMedCrossRefPubMedCentralGoogle Scholar
  124. 124.
    Sanchez-Del-Rio M, Reuter U, Moskowitz MA. New insights into migraine pathophysiology. Curr Opin Neurol. 2006;19(3):294–8.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Eggers SD. Migraine-related vertigo: diagnosis and treatment. Curr Pain Headache Rep. 2007;11(3):217–26.CrossRefGoogle Scholar
  126. 126.
    Salmito MC, Duarte JA, Morganti LOG, Brandao PVC, Nakao BH, Villa TR, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol. 2017;83(4):404–10.PubMedCrossRefPubMedCentralGoogle Scholar
  127. 127.
    Salviz M, Yuce T, Acar H, Karatas A, Acikalin RM. Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial. Laryngoscope. 2016;126(1):169–74.PubMedCrossRefPubMedCentralGoogle Scholar
  128. 128.
    Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006;116(10):1782–6.PubMedCrossRefPubMedCentralGoogle Scholar
  129. 129.
    Silberstein SD. Preventive treatment of migraine: an overview. Cephalalgia. 1997;17(2):67–72.PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931–6.PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Visvanathan N, Kannaian S, Nimmakayala R. Flunarizine for the prophylaxis of vestibular migraine. Neurology Conference: 69th American Academy of Neurology Annual Meeting, AAN. 2017;88(16 Suppl. 1).Google Scholar
  132. 132.
    Peer Mohamed B, Goadsby PJ, Prabhakar P. Safety and efficacy of flunarizine in childhood migraine: 11 years’ experience, with emphasis on its effect in hemiplegic migraine. Dev Med Child Neurol. 2012;54(3):274–7.PubMedCrossRefGoogle Scholar
  133. 133.
    Sanvito WL, Oliveira BC. Prophylactic treatment of migraine: a prospective open study on 100 patients. Arq Neuropsiquiatr. 1993;51(1):31–5.PubMedCrossRefGoogle Scholar
  134. 134.
    Gordon CR, Shupak A. Prevention and treatment of motion sickness in children. CNS Drugs. 1999;12(5):369–81.CrossRefGoogle Scholar
  135. 135.
    Taghdiri F, Togha M, Jahromi SR, Refaeian F. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus. 2014;3:5.CrossRefGoogle Scholar
  136. 136.
    Teggi R, Colombo B, Gatti O, Comi G, Bussi M. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci. 2015;36(10):1869–73.PubMedCrossRefGoogle Scholar
  137. 137.
    Brodsky JR, Cusick BA, Zhou G. Evaluation and management of vestibular migraine in children: experience from a pediatric vestibular clinic. Eur J Paediatr Neurol. 2016;20(1):85–92.PubMedCrossRefGoogle Scholar
  138. 138.
    Staab JP, Eggers SD, Neff BA, Shepard NT. Vestibular migraine and persistent postural-perceptual dizziness: results of a double blind, parallel group, pharmacologic dissection trial using verapamil and sertraline. Cephalalgia. 2015;35:65.Google Scholar
  139. 139.
    Frommer DA, Kulig KW, Marx JA, Rumack B. Tricyclic antidepressant overdose. A review. JAMA. 1987;257(4):521–6.PubMedCrossRefGoogle Scholar
  140. 140.
    Walker Z, Walker RW, Robertson MM, Stansfeld S. Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache. 1998;38(7):523–8.PubMedCrossRefGoogle Scholar
  141. 141.
    Kacperski J, Kabbouche MA, O’Brien HL, Weberding JL. The optimal management of headaches in children and adolescents. Ther Adv Neurol Disord. 2016;9(1):53–68.PubMedCrossRefPubMedCentralGoogle Scholar
  142. 142.
    Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Libr. 2013. 6):CD010610Google Scholar
  143. 143.
    Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973–89.Google Scholar
  144. 144.
    Bisdorff AR. Management of vestibular migraine. Ther Adv Neurol Disord. 2011;4(3):183–91.PubMedCrossRefPubMedCentralGoogle Scholar
  145. 145.
    Celebisoy N, Gokcay F, Karahan C, Bilgen C, Kirazli T, Karapolat H, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol [Internet]. 2016;273(10):2947–51. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/193/CN-01208193/frame.html, https://link.springer.com/content/pdf/10.1007%2Fs00405-015-3874-4.pdf.PubMedCrossRefPubMedCentralGoogle Scholar
  146. 146.
    Baloh RW, Winder A. Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features. Neurology. 1991;41(3):429–33.PubMedCrossRefPubMedCentralGoogle Scholar
  147. 147.
    Griggs RC, Moxley RT, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia response to acetazolamide. Neurology. 1978;28(12):1259.PubMedCrossRefPubMedCentralGoogle Scholar
  148. 148.
    Shirai T, Meyer J, Akiyama H, Mortel K, Wills P. Acetazolamide testing of cerebral vasodilator capacity provokes “vascular” but not tension headaches. Headache J Head Face Pain. 1996;36(10):589–94.CrossRefGoogle Scholar
  149. 149.
    Carmona S, Settecase N. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann N Y Acad Sci. 2005;1039:517–20.PubMedCrossRefPubMedCentralGoogle Scholar
  150. 150.
    Baier B, Winkenwerder E, Dieterich M. “Vestibular migraine”: effects of prophylactic therapy with various drugs. A retrospective study. J Neurol. 2009;256(3):436–42.PubMedCrossRefGoogle Scholar
  151. 151.
    Gode S, Celebisoy N, Kirazli T, Akyuz A, Bilgen C, Karapolat H, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84.PubMedCrossRefGoogle Scholar
  152. 152.
    Cologno D, d’Onofrio F, Castriota O, Petretta V, Casucci G, Russo A, et al. Basilar-type migraine patients responsive to lamotrigine: a 5-year follow-up. Neurol Sci. 2013;34(Suppl 1):S165–6.PubMedCrossRefGoogle Scholar
  153. 153.
    Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004;2:103–8.Google Scholar
  154. 154.
    Gordon C, Kuritzky A, Doweck I, Spitzer O, Shupak A, Hering R. Vestibulo-ocular reflex in migraine patients: the effect of sodium valproate. Headache [Internet]. 1993;33(3):129–32. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/935/CN-00092935/frame.html.CrossRefGoogle Scholar
  155. 155.
    Diener H, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von ZH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia [Internet]. 2005;25(11):1031–41. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/242/CN-00531242/frame.html.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of SurgeryYale University, School of MedicineNew HavenUSA
  2. 2.Departments of Neurology (OL,DN) Neuroscience (DN) and Surgery (DN)Yale University, School of MedicineNew HavenUSA

Personalised recommendations